22 February 2017 (Wednesday) - Transfusion News email

Zika-Positive Blood Donations Can Be Inactivated Using Pathogen Inactivation Technologies

February 15, 2017
Emerging infections, such as the Zika virus (ZIKV), continue to surface due to global travel, migration, and the spread of vectors including mosquitoes. The first ZIKV outbreak occurred in 2007 in the Pacific and has quickly spread to most of the Americas. Blood donations have tested positive [Read More]

Transfusion Testing Strategies for Multiple Myeloma Patients Undergoing Anti-CD38 Therapy

February 10, 2017
Anti-CD38 therapies such as daratumumab have increased survival time for patients with multiple myeloma. This novel therapy, however, interferes with blood compatibility testing. Anti-CD38-sensitized red blood cells agglutinate during testing which could mask the presence of alloantibodies or mimic a high-prevalence alloantibody. Several methods are used to provide safe transfusions [Read More]

No comments:

Post a Comment